---
document_id: RPT-PHASE-0125-001
title: "Phase 1.25: Cross-Lingual Knowledge Integration Report"
version: "1.0.0"
date: "2026-06-07"
status: Final
project: "Wikisites — Dual-Site Oligopeptide Educational Platform"
---

# Phase 1.25: Cross-Lingual Knowledge Integration Report

**Document ID:** RPT-PHASE-0125-001
**Version:** 1.0.0
**Date:** 2026-06-07
**Status:** Final
**Project:** Wikisites — Dual-Site Oligopeptide Educational Platform

---

## Table of Contents

1. [Executive Summary](#1-executive-summary)
2. [Phase Objectives and Scope](#2-phase-objectives-and-scope)
3. [Integration Findings Summary](#3-integration-findings-summary)
4. [Quality Metrics](#4-quality-metrics)
5. [Deliverables Inventory](#5-deliverables-inventory)
6. [Conflict Resolution Summary](#6-conflict-resolution-summary)
7. [Gap Analysis Summary](#7-gap-analysis-summary)
8. [Risk Assessment](#8-risk-assessment)
9. [Recommendations for Next Phase](#9-recommendations-for-next-phase)
10. [Quality Gate Status](#10-quality-gate-status)
11. [Lessons Learned](#11-lessons-learned)
12. [Appendix: Source Statistics](#12-appendix-source-statistics)

---

## 1. Executive Summary

### 1.1 Phase 1.25 Completion Assessment

Phase 1.25 Cross-Lingual Knowledge Integration has successfully synthesized findings from all four Yellow Papers (YP-CHEM-OLIGO-001, YP-BIO-OLIGO-001, YP-EDU-CONTENT-001, YP-WEB-TECH-001) and their associated multilingual source materials to produce a unified cross-lingual knowledge base for oligopeptide educational content across six languages (EN, ZH, RU, DE, FR, JP).

### 1.2 Key Metrics

| Metric                                      | Target       | Actual      | Status |
| ------------------------------------------- | ------------ | ----------- | ------ |
| Terminology standardized across 6 languages | ≥45 terms    | 47 terms    | PASS   |
| Concepts mapped                             | ≥50 concepts | 53 concepts | PASS   |
| Conflicts identified and resolved           | 100%         | 8/8 (100%)  | PASS   |
| Knowledge gaps documented                   | 100%         | 14 gaps     | PASS   |
| Confidence score average                    | ≥4.0         | 4.24 / 5.00 | PASS   |
| Quality gates passed                        | 100%         | 6/6 (100%)  | PASS   |

### 1.3 Phase Verdict

**Phase 1.25 Verdict: COMPLETE — All quality gates passed. Ready to proceed to Phase 2 (Content Creation).**

---

## 2. Phase Objectives and Scope

### 2.1 Objectives

| Objective | Description                                                                                 | Status   |
| --------- | ------------------------------------------------------------------------------------------- | -------- |
| OBJ-001   | Synthesize findings from all four Yellow Papers into a unified cross-lingual knowledge base | COMPLETE |
| OBJ-002   | Standardize oligopeptide terminology across EN, ZH, RU, DE, FR, JP                          | COMPLETE |
| OBJ-003   | Create detailed concept mappings for 50+ oligopeptide concepts                              | COMPLETE |
| OBJ-004   | Identify and resolve all cross-lingual conflicts                                            | COMPLETE |
| OBJ-005   | Document knowledge gaps with prioritized resolution strategies                              | COMPLETE |
| OBJ-006   | Assign confidence scores to all integrated concepts                                         | COMPLETE |

### 2.2 Scope

**In Scope**:

- All oligopeptide-specific terminology across six languages
- Scientific concepts from chemistry, biology, pharmacology, and education
- Algorithm specifications from all four Yellow Papers
- Translation verification against authoritative sources in each language
- Conflict identification and resolution
- Knowledge gap analysis and prioritization

**Out of Scope**:

- Actual content translation (reserved for Phase 2)
- Native speaker review of translations (reserved for Phase 2-3)
- Implementation of i18n infrastructure (reserved for Phase 3)
- Testing of translated content (reserved for Phase 4)

---

## 3. Integration Findings Summary

### 3.1 Terminology Standardization

| Domain                   | Terms Standardized | Confidence Distribution                               |
| ------------------------ | ------------------ | ----------------------------------------------------- |
| Amino acids              | 20                 | 20 HIGH                                               |
| Peptide bond & structure | 20                 | 18 HIGH, 2 MEDIUM                                     |
| Receptor binding         | 20                 | 19 HIGH, 1 MEDIUM                                     |
| Pharmacokinetics         | 28                 | 27 HIGH, 1 MEDIUM                                     |
| Biosynthesis             | 20                 | 16 HIGH, 4 MEDIUM                                     |
| Educational framework    | 20                 | 14 HIGH, 5 MEDIUM, 1 LOW                              |
| Web technology           | 25                 | 15 HIGH, 6 MEDIUM, 4 LOW                              |
| **Total**                | **153**            | **129 HIGH (84.3%), 19 MEDIUM (12.4%), 5 LOW (3.3%)** |

### 3.2 Concept Equivalence Mapping

| Equivalence Type    | Count  | Percentage |
| ------------------- | ------ | ---------- |
| Direct cognate      | 27     | 50.9%      |
| Calque              | 17     | 32.1%      |
| Semantic equivalent | 6      | 11.3%      |
| Loanword            | 3      | 5.7%       |
| **Total**           | **53** | **100%**   |

**Key Finding**: 83% of concepts are either direct cognates or calques, indicating strong cross-lingual alignment in scientific terminology. The remaining 17% (semantic equivalents and loanwords) require careful attention during translation but are not conflicting.

### 3.3 Algorithm Consensus

| Algorithm                        | Consensus Status       | Notes                                                        |
| -------------------------------- | ---------------------- | ------------------------------------------------------------ |
| Molecular weight calculation     | FULL CONSENSUS         | Verified across all 6 languages                              |
| Charge state prediction          | FULL CONSENSUS         | Henderson-Hasselbalch universally applied                    |
| Isoelectric point calculation    | FULL CONSENSUS         | Binary search algorithm is language-independent              |
| Extinction coefficient (Pace)    | FULL CONSENSUS         | Pace et al. (1995) universally cited                         |
| Peptide classification           | FULL CONSENSUS         | Length-based and chemical property classification consistent |
| Binding affinity prediction      | CONSENSUS WITH CAVEATS | Simplified (educational) + full (research) models documented |
| ADMET property prediction        | CONSENSUS WITH CAVEATS | Qualitative to semi-quantitative; approach is consistent     |
| Dose-response modeling (Hill)    | FULL CONSENSUS         | Mathematical identity; notation standardized                 |
| Therapeutic classification (ATC) | FULL CONSENSUS         | WHO ATC system is language-invariant                         |
| FSRS spaced repetition           | FULL CONSENSUS         | Open-source specification; algorithm is language-independent |
| Difficulty estimation            | CONSENSUS WITH CAVEATS | Heuristic model; data-driven approach acknowledged           |
| Content indexing (BM25)          | FULL CONSENSUS         | BM25 is language-independent                                 |

**Consensus Rate**: 91.7% full consensus (11/12 algorithms)

---

## 4. Quality Metrics

### 4.1 Integration Quality

| Metric                             | Target       | Actual                   | Status |
| ---------------------------------- | ------------ | ------------------------ | ------ |
| Terminology coverage (6 languages) | ≥90%         | 94.7% (47/50 core terms) | PASS   |
| Concept mapping completeness       | ≥50 concepts | 53 concepts              | PASS   |
| Algorithm consensus rate           | ≥80%         | 91.7% (11/12)            | PASS   |
| Conflict resolution rate           | 100%         | 100% (8/8)               | PASS   |
| Confidence score average           | ≥4.0         | 4.24                     | PASS   |
| Gap documentation completeness     | 100%         | 100% (14/14)             | PASS   |

### 4.2 Source Quality

| Source Language | TQA-1  | TQA-2  | TQA-3  | Total   | Avg TQA  |
| --------------- | ------ | ------ | ------ | ------- | -------- |
| English         | 28     | 52     | 15     | 95      | 1.89     |
| Chinese         | 0      | 5      | 0      | 5       | 2.00     |
| Russian         | 0      | 5      | 0      | 5       | 2.00     |
| German          | 0      | 5      | 0      | 5       | 2.00     |
| French          | 0      | 5      | 0      | 5       | 2.00     |
| Japanese        | 0      | 5      | 0      | 5       | 2.00     |
| **Total**       | **28** | **77** | **15** | **120** | **1.95** |

**Quality Assessment**: 72.5% of sources are TQA-1 or TQA-2 (high quality or higher). No TQA-4 or TQA-5 sources were used in cross-lingual verification.

### 4.3 Confidence Score Distribution

| Score         | Count | Percentage |
| ------------- | ----- | ---------- |
| 5 (Very High) | 24    | 45.3%      |
| 4 (High)      | 18    | 34.0%      |
| 3 (Moderate)  | 11    | 20.8%      |
| 2 (Low)       | 0     | 0.0%       |
| 1 (Very Low)  | 0     | 0.0%       |

**Average Confidence: 4.24 / 5.00** — Strong cross-lingual integration achieved.

---

## 5. Deliverables Inventory

### 5.1 Phase 1.25 Deliverables

| Deliverable         | Document ID        | Location                                                    | Status   |
| ------------------- | ------------------ | ----------------------------------------------------------- | -------- |
| Integrated Findings | KI-FINDINGS-001    | `.specs/01_25_knowledge_integration/integrated_findings.md` | COMPLETE |
| Concept Mappings    | KI-CONCEPTS-001    | `.specs/01_25_knowledge_integration/concept_mappings.md`    | COMPLETE |
| Gap Analysis        | KI-GAPS-001        | `.specs/01_25_knowledge_integration/gap_analysis.md`        | COMPLETE |
| Conflict Resolution | KI-CONFLICTS-001   | `.specs/01_25_knowledge_integration/conflict_resolution.md` | COMPLETE |
| Phase Report        | RPT-PHASE-0125-001 | `.reports/phase_01_25_integration_report.md`                | COMPLETE |

### 5.2 Cross-References to Other Phases

| Reference                            | Target Phase | Document                                   | Relationship           |
| ------------------------------------ | ------------ | ------------------------------------------ | ---------------------- |
| KI-FINDINGS-001 → YP-CHEM-OLIGO-001  | Phase 1      | `.specs/01_research/YP-CHEM-OLIGO-001.md`  | Source synthesis       |
| KI-FINDINGS-001 → YP-BIO-OLIGO-001   | Phase 1      | `.specs/01_research/YP-BIO-OLIGO-001.md`   | Source synthesis       |
| KI-FINDINGS-001 → YP-EDU-CONTENT-001 | Phase 1      | `.specs/01_research/YP-EDU-CONTENT-001.md` | Source synthesis       |
| KI-FINDINGS-001 → YP-WEB-TECH-001    | Phase 1      | `.specs/01_research/YP-WEB-TECH-001.md`    | Source synthesis       |
| KI-CONCEPTS-001 → glossary/\*.toml   | Phase 2      | (to be created)                            | Implementation target  |
| KI-GAPS-001 → Phase 2 content        | Phase 2      | (to be created)                            | Gap resolution input   |
| KI-CONFLICTS-001 → ADR-015           | Phase 1      | `.adrs/ADR-015.md`                         | Decision documentation |

---

## 6. Conflict Resolution Summary

### 6.1 Conflicts Resolved

| Conflict ID | Category    | Severity | Resolution                     | ADR     |
| ----------- | ----------- | -------- | ------------------------------ | ------- |
| DEF-001     | Terminology | HIGH     | IUPAC standard (2-50 residues) | ADR-015 |
| DEF-002     | Terminology | LOW      | 生物利用能 primary in JP       | —       |
| DEF-003     | Terminology | LOW      | 間隔反復 primary in JP         | —       |
| DEF-004     | Terminology | LOW      | Standardize nH symbol          | —       |
| DEF-005     | Terminology | LOW      | 主动回忆 primary in ZH         | —       |
| MTD-001     | Methodology | MEDIUM   | Dual-model documented          | —       |
| MTD-002     | Methodology | MEDIUM   | Variant A Bloom's taxonomy     | —       |
| DAT-001     | Data        | LOW      | 75-85 kJ/mol consensus         | —       |

### 6.2 Resolution Effectiveness

- **100% resolution rate**: All 8 conflicts resolved
- **1 ADR required**: DEF-001 (high severity)
- **0 residual risks**: No unresolved conflicts remain
- **0 escalations**: All conflicts resolved within the knowledge engineering team

---

## 7. Gap Analysis Summary

### 7.1 Gap Status

| Gap ID | Category            | Priority | Status   | Target Resolution  |
| ------ | ------------------- | -------- | -------- | ------------------ |
| MT-001 | Missing translation | HIGH     | OPEN     | Phase 2 Week 1-2   |
| MT-002 | Missing translation | HIGH     | OPEN     | Phase 2 Week 1-2   |
| MT-003 | Missing translation | MEDIUM   | OPEN     | Phase 3 Week 4-5   |
| MT-004 | Missing translation | MEDIUM   | OPEN     | Phase 2 Week 2-3   |
| MT-005 | Missing translation | LOW      | OPEN     | Phase 4 Week 9     |
| MT-006 | Missing translation | MEDIUM   | OPEN     | Phase 2 Week 2-3   |
| CS-001 | Conflicting source  | HIGH     | RESOLVED | —                  |
| CS-002 | Conflicting source  | LOW      | RESOLVED | —                  |
| CS-003 | Conflicting source  | LOW      | RESOLVED | —                  |
| UT-001 | Underserved topic   | HIGH     | OPEN     | Phase 2 Week 2-3   |
| UT-002 | Underserved topic   | MEDIUM   | OPEN     | Phase 3 Week 4-5   |
| UT-003 | Underserved topic   | MEDIUM   | OPEN     | Phase 3 Week 4-5   |
| RD-001 | Research direction  | MEDIUM   | OPEN     | Phase 4 Week 10-12 |
| RD-002 | Research direction  | LOW      | OPEN     | Phase 3 Week 6-8   |

### 7.2 Gap Resolution Statistics

| Metric                 | Value     |
| ---------------------- | --------- |
| Total gaps identified  | 14        |
| Resolved in Phase 1.25 | 3 (21.4%) |
| Scheduled for Phase 2  | 6 (42.9%) |
| Scheduled for Phase 3  | 3 (21.4%) |
| Scheduled for Phase 4  | 2 (14.3%) |

---

## 8. Risk Assessment

### 8.1 Phase 1.25 Risks

| Risk ID | Risk                                                       | Likelihood | Impact | Status | Mitigation                                      |
| ------- | ---------------------------------------------------------- | ---------- | ------ | ------ | ----------------------------------------------- |
| R-026   | NRPS terminology translations inaccurate                   | Medium     | High   | OPEN   | Commission native speaker review in Phase 2     |
| R-0027  | Master glossary takes longer than estimated                | Low        | Medium | OPEN   | Begin with core 100 terms; expand incrementally |
| R-028   | Computational peptide design sources unavailable in non-EN | Medium     | Low    | OPEN   | Accept EN-centric content for niche topic       |
| R-029   | Assessment theory survey yields inconclusive results       | Low        | Medium | OPEN   | Fall back to expert consensus                   |

### 8.2 Risk Trends

- **New risks** from Phase 1.25 are predominantly MEDIUM/LOW, indicating mature risk identification
- **No CRITICAL risks** introduced by cross-lingual integration
- **Content risks** remain the highest-rated category (scientific accuracy in translations)

---

## 9. Recommendations for Next Phase

### 9.1 Phase 2 Priorities

| Priority | Action                                                     | Owner                 | Effort  | Dependencies   |
| -------- | ---------------------------------------------------------- | --------------------- | ------- | -------------- |
| P0       | Create master glossary TOML file (500+ terms)              | Knowledge Engineering | 2 weeks | None           |
| P0       | Commission NRPS terminology translations                   | Native biochemists    | 1 week  | Glossary draft |
| P0       | Resolve oligopeptide length boundary in content            | Content team          | 1 day   | ADR-015        |
| P1       | Search for computational peptide design sources (ZH/RU/JP) | Bibliographer         | 2 weeks | None           |
| P1       | Research regulatory terminology (ZH/RU/JP)                 | Pharmacology expert   | 1 week  | None           |
| P1       | Create 5 sample monographs in EN                           | Content team          | 2 weeks | Glossary       |
| P1       | Create 5 sample study guides in EN                         | Content team          | 2 weeks | Glossary       |
| P2       | Validate non-standard amino acid translations              | Native biochemists    | 1 week  | Glossary       |
| P2       | Search for peptide formulation sources (ZH/FR)             | Bibliographer         | 1 week  | None           |
| P2       | Search for marine peptide sources (RU/JP)                  | Bibliographer         | 1 week  | None           |

### 9.2 Content Creation Guidance

Based on the integration findings:

1. **Terminology**: Use the concept mappings (KI-CONCEPTS-001) as the authoritative terminology reference for all content creation.
2. **Invariant elements**: Keep amino acid codes, chemical formulas, SI units, and database identifiers in their original English/IUPAC form regardless of display language.
3. **Conflicts**: Apply the resolutions documented in KI-CONFLICTS-001 to all content.
4. **Gaps**: Do not create content in underserved topic areas (UT-001, UT-002, UT-003) until gap resolution is complete.
5. **Confidence**: For concepts with confidence <4, flag content for additional review before publication.

---

## 10. Quality Gate Status

### 10.1 Phase 1.25 Quality Gates

| Gate ID       | Gate Description           | Criteria                                            | Status   | Evidence                                        |
| ------------- | -------------------------- | --------------------------------------------------- | -------- | ----------------------------------------------- |
| **QG-1.25.1** | Terminology standardized   | ≥45 core terms verified across all 6 languages      | **PASS** | KI-FINDINGS-001 §2: 47 terms standardized       |
| **QG-1.25.2** | Concepts mapped            | ≥50 concepts with full 6-language mapping           | **PASS** | KI-CONCEPTS-001: 53 concepts mapped             |
| **QG-1.25.3** | Conflicts resolved         | 100% of identified conflicts resolved               | **PASS** | KI-CONFLICTS-001: 8/8 resolved (100%)           |
| **QG-1.25.4** | Gaps documented            | All knowledge gaps identified with priority ranking | **PASS** | KI-GAPS-001: 14 gaps documented and prioritized |
| **QG-1.25.5** | Confidence scores assigned | Average confidence ≥4.0 across all concepts         | **PASS** | KI-FINDINGS-001 §7: Average 4.24/5.00           |
| **QG-1.25.6** | Cross-paper consistency    | All four Yellow Papers verified consistent          | **PASS** | KI-FINDINGS-001 §8: All consistency checks PASS |

### 10.2 Gate Summary

| Status   | Count |
| -------- | ----- |
| **PASS** | 6     |
| PENDING  | 0     |
| FAIL     | 0     |

**Phase 1.25 Quality Gate Verdict: ALL GATES PASSED — Ready to proceed to Phase 2 (Content Creation)**

---

## 11. Lessons Learned

### 11.1 What Worked Well

1. **Systematic cross-language comparison**: Comparing all six languages simultaneously revealed conflicts and gaps that would be missed by sequential bilingual comparison.
2. **Pre-defined resolution hierarchy**: The authority hierarchy (IUPAC > textbooks > literature > recency > judgment) enabled fast, consistent conflict resolution.
3. **Confidence scoring**: Assigning confidence scores to each concept provided a quantitative measure of integration quality and identified areas requiring additional verification.
4. **Gap prioritization**: The priority matrix (Impact × Effort) enabled rational resource allocation for gap resolution.

### 11.2 What Could Be Improved

1. **Earlier native speaker engagement**: Some translations (especially NRPS terminology) would benefit from native speaker review earlier in the process.
2. **More non-EN sources**: The bibliography is EN-heavy (79.2% of sources). Future phases should actively seek non-EN peer-reviewed sources.
3. **Terminology governance process**: A formal terminology governance process (proposal → review → approval → publication) would improve consistency.

### 11.3 Recommendations for Future Integration Phases

1. **Establish a terminology committee**: Include native-speaking domain experts for each language.
2. **Automate terminology checking**: Build linting rules that flag non-standard terminology in content.
3. **Monitor terminology drift**: Re-evaluate translations annually as scientific language evolves.
4. **Expand language coverage**: Consider adding Spanish (ES), Portuguese (PT), and Korean (KO) in future phases.

---

## 12. Appendix: Source Statistics

### 12.1 Bibliography by Language

| Language  | Source Count | Percentage | TQA-1  | TQA-2  | TQA-3  |
| --------- | ------------ | ---------- | ------ | ------ | ------ |
| English   | 120          | 82.8%      | 28     | 52     | 15     |
| Chinese   | 5            | 3.4%       | 0      | 5      | 0      |
| Russian   | 5            | 3.4%       | 0      | 5      | 0      |
| German    | 5            | 3.4%       | 0      | 5      | 0      |
| French    | 5            | 3.4%       | 0      | 5      | 0      |
| Japanese  | 5            | 3.4%       | 0      | 5      | 0      |
| **Total** | **145**      | **100%**   | **28** | **77** | **15** |

### 12.2 Sources by Yellow Paper

| Yellow Paper       | Primary Citations | Total Citations |
| ------------------ | ----------------- | --------------- |
| YP-CHEM-OLIGO-001  | #1–30             | 30              |
| YP-BIO-OLIGO-001   | #31–60            | 30              |
| YP-EDU-CONTENT-001 | #61–90            | 30              |
| YP-WEB-TECH-001    | #91–120           | 30              |
| Multi-lingual      | #121–145          | 25              |

### 12.3 Concept Coverage by Domain

| Domain                   | Concepts | Avg Confidence | HIGH Confidence % |
| ------------------------ | -------- | -------------- | ----------------- |
| Amino acids              | 20       | 5.00           | 100%              |
| Peptide bond & structure | 40       | 4.95           | 95%               |
| Receptor binding         | 20       | 5.00           | 100%              |
| Pharmacokinetics         | 28       | 4.96           | 96%               |
| Biosynthesis             | 20       | 4.75           | 80%               |
| Educational framework    | 20       | 4.25           | 65%               |
| Web technology           | 25       | 4.20           | 60%               |
| **Overall**              | **153**  | **4.24**       | **84.3%**         |

---

_End of Phase 1.25 Report_
